title: Psychopathological symptoms in patients with primary hyperaldosteronism--possible pathways.
abstract: A close comorbidity between endocrine diseases and psychopathological symptoms has been described in the literature. Until now only a few studies have reported about an increased anxiety and depressive symptoms in patients with primary hyperaldosteronism (PHA). The exact pathways of psychiatric comorbidities have not been totally clarified yet, although the renin-angiotensin-aldosterone-system has gained more attention in research on anxiety and depression. There are several structures and factors, which could mediate anxiety or a depressive symptomatology. Additionally a possible influence of the standardised treatment with a mineralocorticoidreceptor (MR) antagonist or adrenalectomy should be investigated as they have been shown to affect mood. Psychiatric comorbidities are not only an additional burden in these patients, but as depression and anxiety are additional risk factors in patients with cardiovascular diseases. Possible pathomechanisms in the relation between PHA and psychiatric symptoms should be more closely investigated. For the clinical practice a regular screening for psychiatric comorbidities and an adequate treatment are required.
authors.affiliation: Medizinische Klinik Innenstadt, Klinikum der Ludwig-Maximilians-Universität München, München, Germany. heike.kuenzel@med.uni-muenchen.de
authors.forename: H E
authors.initials: HE
authors.lastname: Künzel
mesh_terms: D000450:Aldosterone / Q000378:metabolism; D000818:Animals; D001007:Anxiety; D003863:Depression; D006801:Humans; D006929:Hyperaldosteronism / Q000150:complications* / Q000378:metabolism / Q000523:psychology*; D001523:Mental Disorders / Q000209:etiology* / Q000378:metabolism / Q000523:psychology; D011599:Psychopathology
chemical_list: D000450:Aldosterone